Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00949065Phase 3Withdrawn
A Phase 3 trial of intravenous immunoglobulin G in Complex Regional Pain Syndrome Type 1 (CRPS-1), sponsored by Justus Liebig University Giessen. Planned start Aug 2009; status: withdrawn.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00949065.